Li Wei
Zhengzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
NAT10 and E2F1 Orchestrate CKAP5-Mediated Progression in Esophageal Squamous Cell Carcinoma.
Journal: Journal of gastroenterology and hepatology
Published: September 24, 2025
Arntl-induced upregulation of DUSP1 inhibits tumor progression in esophageal squamous cell carcinoma by inactivating ERK signaling.
Journal: Cancer biology & therapy
Published: September 28, 2024
CT-based delta-radiomics for predicting pathological response to neoadjuvant immunochemotherapy in esophageal squamous cell carcinoma: a multicenter study.
Journal: BMC medical imaging
Published: July 13, 2024
Exosomal circ_0026611 contributes to lymphangiogenesis by reducing PROX1 acetylation and ubiquitination in human lymphatic endothelial cells (HLECs).
Journal: Cellular & molecular biology letters
Published: May 08, 2022
Identification of a novel circ_0001946/miR-1290/SOX6 ceRNA network in esophageal squamous cell cancer.
Journal: Thoracic cancer
Published: January 22, 2022
Circular RNA CircPVT1 Inhibits 5-Fluorouracil Chemosensitivity by Regulating Ferroptosis Through MiR-30a-5p/FZD3 Axis in Esophageal Cancer Cells.
Journal: Frontiers in oncology
Published: September 30, 2021
MicroRNA-2053 involves in the progression of esophageal cancer by targeting KIF3C.
Journal: Cell cycle (Georgetown, Tex.)
Published: May 31, 2021
Dual role of twist1 in cancer-associated fibroblasts and tumor cells promoted epithelial-mesenchymal transition of esophageal cancer.
Journal: Experimental cell research
Published: January 12, 2018
Comparison between docetaxel plus cisplatin and cisplatin plus fluorouracil in the neoadjuvant chemoradiotherapy for local advanced esophageal squamous cell carcinoma
Journal: Zhonghua zhong liu za zhi [Chinese journal of oncology]
Published: January 08, 2013
Showing 1-9 of 9
Last Updated: 09/26/2026